CS and pulmonary hypertension, primary, 1: mTORC1 inhibition showed a significant reduction in citrate synthase activity (P < 0.0001, n = 6/each group; Fig. 5g), whereas citrate synthase activity was comparable between rictor silenced and control PHT cells (Fig. 5h).